Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2

Interventions

Fulvestrant 26Letrozole 25Specimen Handling 19ribociclib 18Capecitabine 16pembrolizumab 15palbociclib 13Trastuzumab 13Paclitaxel 13abemaciclib 12Tamoxifen 12Anastrozole 12exemestane 11Magnetic Resonance Spectroscopy 11trastuzumab deruxtecan 10Carboplatin 10Biopsy 9pertuzumab 8Goserelin 8inavolisib 6Standard of Care 6Cyclophosphamide 6olaparib 5giredestrant 5elacestrant 5Taxes 5Radiotherapy 5Radiation 5130-nm albumin-bound paclitaxel 5pyrotinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Breast Neoplasms × Biopsy, Large-Core Needle × 30 days × Clear all
NCT06127979 2026-06-02

A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
42 enrolled
Breast

Breast Neoplasms

NCT03524430 2026-05-28

BREVITY

Rna Diagnostics Inc.

Phase NA Active not recruiting
801 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡